Erythropoietin therapy: need for rationality and active surveillance

Haematologica. 2003 Jun;88(6):601-5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anemia / complications
  • Anemia / drug therapy*
  • Anemia / etiology
  • Autoimmune Diseases / chemically induced
  • Autoimmune Diseases / diagnosis
  • Clinical Trials as Topic
  • Doping in Sports
  • Erythropoietin / adverse effects
  • Erythropoietin / biosynthesis
  • Erythropoietin / deficiency
  • Erythropoietin / therapeutic use*
  • Humans
  • Kidney Diseases / complications
  • Myelodysplastic Syndromes / complications
  • Neoplasms / complications
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure / chemically induced
  • Red-Cell Aplasia, Pure / diagnosis
  • Treatment Outcome
  • Uremia / complications

Substances

  • Recombinant Proteins
  • Erythropoietin